合計 50 件の最近のインサイダー取引記録が記録されています Coya Therapeutics, Inc. (COYA), 内訳は 45 件の買い および 2 件の売り. インサイダー買い総額は $14.2M インサイダー売り総額は $594.49K.
最近活動のある主要インサイダーには Snyder David S, Berman Howard, Grossman Fred. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — COYA
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-01-22 |
Snyder David S |
Chief Financial Officer |
RSU 付与（制限付株式） |
140,041 |
$4.73 |
$662.39K |
140,041 |
| 2026-01-22 |
Berman Howard |
Executive Chairman |
RSU 付与（制限付株式） |
15,257 |
$4.73 |
$72.17K |
15,257 |
| 2026-01-22 |
Grossman Fred |
Chief Medical Officer |
RSU 付与（制限付株式） |
140,041 |
$4.73 |
$662.39K |
140,041 |
| 2026-01-22 |
Swaminathan Arun |
Chief Executive Officer |
RSU 付与（制限付株式） |
293,983 |
$4.73 |
$1.39M |
293,983 |
| 2026-01-02 |
Ross Wilbur L Jr |
Director |
RSU 付与（制限付株式） |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2026-01-02 |
Goldstein Dov A Md |
Director |
RSU 付与（制限付株式） |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2026-01-02 |
Weinand Dieter |
Director |
RSU 付与（制限付株式） |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2026-01-02 |
Villalobos Anabella |
Director |
RSU 付与（制限付株式） |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2026-01-02 |
Lee Ann |
Director |
RSU 付与（制限付株式） |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2025-08-18 |
Goldstein Dov A Md |
Director |
オプション行使（売却） |
17,557 |
$1.09 |
$19.14K |
- |
| 2025-02-25 |
Ross Wilbur L Jr |
Director |
RSU 付与（制限付株式） |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-02-25 |
Goldstein Dov A Md |
Director |
RSU 付与（制限付株式） |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-02-25 |
Weinand Dieter |
Director |
RSU 付与（制限付株式） |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-02-25 |
Villalobos Anabella |
Director |
RSU 付与（制限付株式） |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-02-25 |
Lee Ann |
Director |
RSU 付与（制限付株式） |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-01-09 |
Snyder David S |
Chief Financial Officer |
RSU 付与（制限付株式） |
140,562 |
$6.07 |
$853.21K |
140,562 |
| 2025-01-09 |
Berman Howard |
Director |
RSU 付与（制限付株式） |
150,602 |
$6.07 |
$914.15K |
150,602 |
| 2025-01-09 |
Grossman Fred |
Chief Medical Officer |
RSU 付与（制限付株式） |
140,562 |
$6.07 |
$853.21K |
140,562 |
| 2025-01-09 |
Swaminathan Arun |
Chief Executive Officer |
RSU 付与（制限付株式） |
240,964 |
$6.07 |
$1.46M |
240,964 |
| 2025-01-01 |
Ross Wilbur L Jr |
Director |
RSU 付与（制限付株式） |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2025-01-01 |
Goldstein Dov A Md |
Director |
RSU 付与（制限付株式） |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2025-01-01 |
Weinand Dieter |
Director |
RSU 付与（制限付株式） |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2025-01-01 |
Villalobos Anabella |
Director |
RSU 付与（制限付株式） |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2025-01-01 |
Lee Ann |
Director |
RSU 付与（制限付株式） |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2024-11-14 |
Snyder David S |
Chief Financial Officer |
情報に基づく買い |
1,800 |
$7.19 |
$12.93K |
8,800 |
| 2024-11-13 |
Swaminathan Arun |
Chief Executive Officer |
情報に基づく買い |
5,000 |
$7.36 |
$36.8K |
10,000 |
| 2024-11-11 |
Grossman Fred |
Chief Medical Officer |
情報に基づく買い |
2,710 |
$7.37 |
$19.97K |
2,710 |
| 2024-11-11 |
Swaminathan Arun |
Chief Executive Officer |
情報に基づく買い |
5,000 |
$7.34 |
$36.69K |
5,000 |
| 2024-08-19 |
Swaminathan Arun |
Director |
処分 |
70,596 |
$8.15 |
$575.36K |
- |
| 2024-06-03 |
Snyder David S |
Chief Financial Officer |
RSU 付与（制限付株式） |
70,596 |
$8.15 |
$575.36K |
70,596 |
| 2024-06-03 |
Berman Howard |
Chief Executive Officer |
RSU 付与（制限付株式） |
163,663 |
$8.15 |
$1.33M |
163,663 |
| 2024-06-03 |
Grossman Fred |
Chief Medical Officer |
RSU 付与（制限付株式） |
70,596 |
$8.15 |
$575.36K |
70,596 |
| 2024-01-31 |
Snyder David S |
Chief Financial Officer |
RSU 付与（制限付株式） |
81,819 |
$5.90 |
$482.73K |
81,819 |
| 2024-01-31 |
Berman Howard |
Chief Executive Officer |
RSU 付与（制限付株式） |
189,680 |
$5.90 |
$1.12M |
189,680 |
| 2024-01-31 |
Grossman Fred |
Chief Medical Officer |
RSU 付与（制限付株式） |
74,069 |
$5.90 |
$437.01K |
74,069 |
| 2024-01-02 |
Ross Wilbur L Jr |
Director |
RSU 付与（制限付株式） |
10,000 |
$6.97 |
$69.7K |
10,000 |
| 2024-01-01 |
Goldstein Dov A Md |
Director |
RSU 付与（制限付株式） |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2024-01-01 |
Weinand Dieter |
Director |
RSU 付与（制限付株式） |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2024-01-01 |
Garren Hideki |
Director |
RSU 付与（制限付株式） |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2024-01-01 |
Villalobos Anabella |
Director |
RSU 付与（制限付株式） |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2024-01-01 |
Lee Ann |
Director |
RSU 付与（制限付株式） |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2023-12-19 |
Ross Wilbur L Jr |
Director |
不明 |
- |
- |
- |
165,016 |
| 2023-08-22 |
Lee Ann |
Director |
情報に基づく買い |
1,000 |
$3.62 |
$3.62K |
17,479 |
| 2023-08-18 |
Weinand Dieter |
Director |
不明 |
- |
- |
- |
- |
| 2023-08-18 |
Weinand Dieter |
Director |
RSU 付与（制限付株式） |
10,000 |
$3.43 |
$34.3K |
10,000 |
| 2023-07-17 |
Grossman Fred |
Officer |
不明 |
- |
- |
- |
- |
| 2023-07-17 |
Grossman Fred |
Chief Medical Officer |
RSU 付与（制限付株式） |
74,069 |
$4.25 |
$314.79K |
74,069 |
| 2023-02-27 |
Snyder David S |
Chief Financial Officer |
RSU 付与（制限付株式） |
115,000 |
$3.85 |
$442.75K |
115,000 |
| 2023-02-27 |
Hepner Adrian |
Chief Medical Officer |
RSU 付与（制限付株式） |
115,000 |
$3.85 |
$442.75K |
115,000 |
| 2023-02-27 |
Berman Howard |
Chief Executive Officer |
RSU 付与（制限付株式） |
165,000 |
$3.85 |
$635.25K |
165,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
